FindTrial
Sign In

Estimate Glycemic index of Murchit Atta as compare to Regular Atta

An open label crossover study to estimate Glycemic index of Murchit Atta as compare to Regular Atta in a patients with Type 2 Diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019386
Enrollment
12
Registered
2019-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Murchit Atta: Cycle 1 After overnight fasting Type 2 Diabetic Subjects are given Test Food (Murchit Atta) at the recommended amount which should equal 50 gm of carbohydrate Blood sample

Sponsors

Madhavbaug Multidisciplinary Cardiac Care Clinics and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex in the age group between 18 to 50 years (Both Inclusive) 2. Willing to provide written informed consent 3. Patients diagnosed to be suffering from Type 2 diabetes mellitus taking oral hypoglycemic drugs and with blood sugar stabilized within normal range(Fasting sugar level < 110 mg/dl and Postprandial sugar level < 140 mg/dl )

Exclusion criteria

Exclusion criteria: 1.Patients of either sex having age below 18 and above 50 2. Not willing to provide written inform consent 3. Patients diagnosed as Type 1 diabetes mellitus 4. Patients with past 30 days history A) Any major illness that required hospitalization B) acute exacerbation of any ongoing chronic medical illness e.g. Congestive cardiac failure Hepatitis Hypotensive episodes HIV etc Medications requiring change of doses for treatment of the chronic illness 5. Patients suffering from severe cardiac renal liver or any other organ impairment. 6. History of seizures epilepsy or any neurological disorders 7. Recent history of dehydration from diarrhoea vomiting or any other reason within a period of 24 hours prior to enrolment in the study 8. Patient with any history of food allergy or any ingredient of investigational Murchit atta 9. Pregnant or lactating females

Design outcomes

Primary

MeasureTime frame
To estimate the Glycemic index of Murchit Atta in patients with Type 2 diabetes mellitusTimepoint: 7 days—

Secondary

MeasureTime frame
To see the effect of Murchit Atta on T2DMTimepoint: 7 days—

Countries

India

Contacts

Public ContactDr Anjali Sable

Milagro Clinical Research

anjali@milagroclinicalresearch.com7400407196

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026